SHR-7782

· Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-7782, covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors [Phase 1]